Skip to content
Scita Health
Two professional women in conversation

Partner with Scita

Building precision prevention, together.

Scita is a clinical decision support system designed to help understand whether midlife symptoms signal perimenopause, another condition, or both. It produces a structured summary to support the conversation with the doctor, and evidence-based guidance for the woman. We work with clinicians, organisations, payers and researchers who share our mission.

Email us

Or write to us directly at hello@scita.health.

For Clinicians

Patients who arrive prepared

A sex-specific analysis of the High-STEACS trial (The Lancet) found that women-specific cardiac thresholds increased detection of heart injury in women by 42%.1

Scita helps your patients arrive with more than a symptom list. The doctor-ready summary maps symptom patterns across body systems to support your assessment, helping you see whether symptoms may relate to perimenopause, another condition, or both, before the appointment begins.

  • A structured, differential view across body systems to support your assessment, not just symptom logs
  • A navigation pathway that supports earlier, more informed referrals to the right specialist
  • An invitation to take part in our clinical validation pathway

For Organisations & Employers

Prevention as a workplace benefit

The IHE Nordic study (2024) estimated €865 million in annual productivity losses across the Nordic countries from moderate-to-severe menopausal symptoms.2

Offer your people an evidence-based, private prevention companion during the menopause transition, when cardiovascular, metabolic and musculoskeletal risk rises significantly. Designed to support long-term health and retention.

  • A private, GDPR-first companion built on EU infrastructure
  • Differential triage that catches emerging health risks, not just menopause symptoms
  • A benefit that supports a stage of life many workplaces overlook

For Insurers & Payers

Earlier navigation in the highest-risk window

Cardiovascular disease costs EU health systems around €111 billion a year in direct healthcare expenditure (European Commission).3

Scita helps surface whether your members’ symptoms may signal emerging cardiovascular, metabolic, or musculoskeletal risk alongside perimenopause, supporting earlier conversations and prevention planning before costly conditions develop.

  • Members who understand their risk profile and can navigate care earlier
  • Differential identification of conditions that drive future claims cost
  • Designed to support healthier long-term trajectories (no outcome guarantees)

Research & Academic

Building the evidence base together

Only 7% of healthcare research focuses on conditions that affect women exclusively (World Economic Forum, 2025).4

We are preparing a clinical validation pathway with Nordic research partners and welcome collaboration on study design and evidence generation.

  • Collaboration on study design and evidence generation
  • Work that is built toward MDR readiness
  • A shared commitment to rigorous, GRADE-graded evidence

Join Our Mission

We all have at least one woman in our lives: a mother, a sister, a partner, a daughter. Our mission is simple: none of them should have to suffer from what can be prevented.

We build mission-oriented partnerships with people and organisations who share that conviction. If that is you, tell us how you would like to work together. We read every message.

Email us

Or write to us directly at hello@scita.health.

Built on rigorous standards